TBS Reveal

Diagnostics and imaging · by Medimaps Group

An AI-based software for opportunistic bone fragility assessment using routine X-rays.

What it does

An AI-based software for opportunistic bone fragility assessment using routine X-rays.

  • Fracture risk assessment
  • Bone microarchitecture evaluation
  • Osteoporosis screening
  • Clinical trial research
Category
Diagnostics and imaging
Built for
Healthcare and life sciences
Users
Healthcare professionals, Orthopedic surgeons, Pharmaceutical organizations, Contract research organizations (CROs)
Public API
Not offered

Not yet disclosed: deployment options, platforms, languages and support channels.

Pricing

Pricing isn't published

Medimaps Group doesn't list prices publicly. Ask them for a quote.

Security and compliance

As reported by Medimaps Group. Ask for audit reports before you buy.

  • ISO 13485:2016 (certificate C831121)Certified
  • MDSAPCertified
  • FDA 510(k) (TBS Insight)Compliant
  • CE MDR (TBS Reveal)Certified

Reviews

No reviews yet

Reviews come from people who use TBS Reveal at work. Share how your team uses it to help other buyers decide.

Alternatives

Is this your product?

Claim it to keep details accurate and submit evidence for the next ranking review.

Claim TBS Reveal